| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 |
| Sales | 648 | 432 | 0 | 5,042 | 4,081 |
| Sales Growth | +50.15% | unch | -100.00% | +23.55% | +2,035.11% |
| Net Income | -15,976 | -37,055 | -54,619 | -21,463 | -12,287 |
| Net Income Growth | +56.88% | +32.16% | -154.48% | -74.68% | +2.46% |
Core One Labs Inc
(COOL.CN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Core One Labs Inc is a biotechnology company. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.
Fiscal Year End Date: 12/31